Overall rank by patents
#30,832
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2020–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).
The verdict
According to USPTO PatentsView, Angelcare ranks #30,832 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R30832 · US Corporation #30,832 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Ampsource Biopharma Shanghai Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Angelcare Feeding USA · this assignee
24 score
3D Lighting… · lowest
7 score
What this shows Angelcare's Innovation Score is 23.8/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Angelcare Feeding USA, LLC is a focused PatentsView assignee: 5 CPC subclasses with 12.5% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2021 (5 grants) versus a trough of 1 in 2020. By volume, Angelcare sits between Ampsource Biopharma Shanghai Inc. and Answeray Inc..
Angelcare Feeding USA, LLC shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Ampsource Biopharma Shanghai Inc.
8 patents
Amvalor
8 patents
Anaergia B.V.
8 patents
Analogix International LLC
8 patents
Angle North America, Inc.
8 patents
Ankobot (SHENZHEN) Smart Technologies Co., Ltd.
8 patents
Annovis BIO, Inc.
8 patents
Answeray Inc.
8 patents
Angelcare Feeding USA, LLC
8 patents
What this shows Angelcare holds 8 patents at rank #30,775, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #30,775 in granted patent volume.
Other assignees with the most granted patents in Angelcare's primary technology class.
Angelcare's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 13th percentile higher than 13% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 12.5% |
| 2021 | 5 | 62.5% |
| 2022 | 2 | 25.0% |
Top 5 of 5 technology areas
Overall rank by patents
#30,832
of 49,997 tracked assignees
23.8 out of 100
What to do with this data
Angelcare Feeding USA, LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.